Adiponectin and atherosclerosis in rheumatoid arthritis

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Dessein, Patrick H ^a   Tsang, Linda ^a   Solomon, Ahmed ^b   Woodiwiss, Angela J ^b   Millen, Aletta M E ^a   Norton, Gavin R ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; HIGH MOLECULAR WEIGHT ADIPONECTIN; RESISTIN; UNCLASSIFIED DRUG;

ABDOMINAL OBESITY; ADULT; ARTICLE; BLACK PERSON; CARDIOVASCULAR RISK; CAROTID ARTERY; CAROTID ATHEROSCLEROSIS; CAROTID ULTRASOUND; CAUCASIAN; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOGRAPHY; FRAMINGHAM RISK SCORE; HUMAN; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; MOLECULAR WEIGHT; PREVALENCE; RHEUMATOID ARTHRITIS; WAIST CIRCUMFERENCE; ATHEROSCLEROSIS; CAROTID ARTERY DISEASE; FEMALE; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADIPONECTIN; ARTHRITIS, RHEUMATOID; ATHEROSCLEROSIS; CAROTID ARTERY DISEASES; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED;

EID: 84903643301     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/358949     Document Type: Article

References (60)

1. Dessein P. H., Norton G. R., Woodiwiss A. J., Joffe B. I., Wolfe F., Influence of nonclassical cardiovascular-risk factors on the accuracy of predicting subclinical atherosclerosis in rheumatoid arthritis. Journal of Rheumatology 2007 34 5 943 951 2-s2.0-34248676552 (Pubitemid 46774836)
2. Solomon D. H., Kremer J., Curtis J. R., Hochberg M. C., Reed G., Tsao P., Farkouh M. E., Setoguchi S., Greenberg J. D., Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity. Annals of the Rheumatic Diseases 2010 69 11 1920 1925 2-s2.0-77956503955 10.1136/ard.2009.122226
3. Nurmohamed M. T., Kitas G., Cardiovascular risk in rheumatoid arthritis and diabetes: how does it compare and when does it start? Annals of the Rheumatic Diseases 2010 70 6 881 883 2-s2.0-79955871936 10.1136/ard.2010.145839
4. Peters M. J. L., Symmons D. P. M., McCarey D., Dijkmans B. A. C., Nicola P., Kvien T. K., McInnes I. B., Haentzschel H., Gonzalez-Gay M. A., Provan S., Semb A., Sidiropoulos P., Kitas G., Smulders Y. M., Soubrier M., Szekanecz Z., Sattar N., Nurmohamed M. T., EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Annals of the Rheumatic Diseases 2010 69 2 325 331 2-s2.0-75749118959 10.1136/ard.2009.113696
5. Crowson C. S., Gabriel S. E., Towards improving cardiovascular risk management in patients with rheumatoid arthritis: the need for accurate risk assessment. Annals of the Rheumatic Diseases 2011 70 5 719 721 2-s2.0-79953309050 10.1136/ard.2010.145482
6. Dessein P. H., Semb A. G., Could cardiovascular disease risk stratification and management in rheumatoid arthritis be enhanced? Annals of the Rheumatic Diseases 2013 72 11 1743 1746 2-s2.0-84882506411 10.1136/annrheumdis- 2013-203911
7. Arita Y., Kihara S., Ouchi N., Takahashi M., Maeda K., Miyagawa J.-I., Hotta K., Shimomura I., Nakamura T., Miyaoka K., Kuriyama H., Nishida M., Yamashita S., Okubo K., Matsubara K., Muraguchi M., Ohmoto Y., Funahashi T., Matsuzawa Y., Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochemical and Biophysical Research Communications 1999 257 1 79 83 2-s2.0-0033515761 10.1006/bbrc.1999.0255 (Pubitemid 29299050)
8. Yamamoto Y., Hirose H., Saito I., Tomita M., Taniyama M., Matsubara K., Okazaki Y., Ishii T., Nishikai K., Saruta T., Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population. Clinical Science 2002 103 2 137 142 2-s2.0-0036349010
9. Shehzad A., Iqbal W., Shehzad O., Lee Y. S., Adiponectin: regulation of its production and its role in human diseases. Hormones 2012 11 1 8 20 2-s2.0-84859023893
10. Fantuzzi G., Mazzone T., Adipose tissue and atherosclerosis: exploring the connection. Arteriosclerosis, Thrombosis, and Vascular Biology 2007 27 5 996 1003 2-s2.0-34247325960 10.1161/ATVBAHA.106.131755 (Pubitemid 46641984)
11. Tanida M., Shen J., Horii Y., Matsuda M., Kihara S., Funahashi T., Shimomura I., Sawai H., Fukuda Y., Matsuzawa Y., Nagai K., Effects of adiponectin on the renal sympathetic nerve activity and blood pressure in rats. Experimental Biology and Medicine 2007 232 3 390 397 2-s2.0-33847391123 (Pubitemid 46334055)
12. Wannamethee S. G., Tchernova J., Whincup P., Lowe G. D., Rumley A., Brown K., Cherry L., Sattar N., Associations of adiponectin with metabolic and vascular risk parameters in the British Regional Heart Study reveal stronger links to insulin resistance-related than to coronory heart disease risk-related parameters. International Journal of Obesity 2007 31 7 1089 1098 2-s2.0-34250854033 10.1038/sj.ijo.0803544 (Pubitemid 46987759)
13. Iwashima Y., Katsuya T., Ishikawa K., Ouchi N., Ohishi M., Sugimoto K., Fu Y., Motone M., Yamamoto K., Matsuo A., Ohashi K., Kihara S., Funahashi T., Rakugi H., Matsuzawa Y., Ogihara T., Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension 2004 43 6 1318 1323 2-s2.0-2542473288 10.1161/01.HYP.0000129281.03801.4b (Pubitemid 38691756)
14. Li S., Shin H. J., Ding E. L., van Dam R. M., Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA-Journal of the American Medical Association 2009 302 2 179 188 2-s2.0-67650169799 10.1001/jama.2009.976
15. Lara-Castro C., Luo N., Wallace P., Klein R. L., Garvey W. T., Adiponectin multimeric complexes and the metabolic syndrome trait cluster. Diabetes 2006 55 1 249 259 2-s2.0-33644760456 10.2337/diabetes.55.1.249 (Pubitemid 43343322)
16. Kobayashi H., Ouchi N., Kihara S., Walsh K., Kumada M., Abe Y., Funahashi T., Matsuzawa Y., Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin. Circulation Research 2004 94 4 e27 e31 2-s2.0-2942720979
17. Krysiak R., Handzlik-Orlik G., Okopien B., The role of adipokines in connective tissue diseases. European Journal of Nutrition 2012 51 5 513 528 2-s2.0-84864711303 10.1007/s00394-012-0370-0
18. Frommer K., Schäffler A., Büchler C., Steinmeyer J., Rickert M., Rehart S., Brentano F., Gay S., Müller-Ladner U., Neumann E., Adiponectin isoforms: a potential therapeutic target in rheumatoid arthritis? Annals of the Rheumatic Diseases 2012 71 10 1724 1732 2-s2.0-84866096056 10.1136/annrheumdis-2011-200924
19. Frommer K. W., Zimmermann B., Meier F. M. P., Schröder D., Heil M., Schäffler A., Büchler C., Steinmeyer J., Brentano F., Gay S., Müller-Ladner U., Neumann E., Adiponectin-mediated changes in effector cells involved in the pathophysiology of rheumatoid arthritis. Arthritis and Rheumatism 2010 62 10 2886 2899 2-s2.0-77957355863 10.1002/art.27616
20. Hahn B. H., Lourenço E. V., McMahon M., Skaggs B., Le E., Anderson M., Iikuni N., Lai C. K., La Cava A., Pro-inflammatory high-density lipoproteins and atherosclerosis are induced in lupus-prone mice by a high-fat diet and leptin. Lupus 2010 19 8 913 917 2-s2.0-77954040617 10.1177/ 0961203310364397
21. Dessein P. H., Norton G. R., Badenhorst M., Woodiwiss A. J., Solomon A., Rheumatoid arthritis impacts on the independent relationships between circulating adiponectin concentrations and cardiovascular metabolic risk. Mediators of Inflammation 2013 2013 9 2-s2.0-84877264025 10.1155/2013/461849 461849
22. Otero M., Logo R., Gomez R., Logo F., Dieguez C., Gómez-Reino J. J., Gualillo O., Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases 2006 65 9 1198 1201 2-s2.0-33747786726 10.1136/ard.2005.046540 (Pubitemid 44277396)
23. Popa C., Netea M. G., de Graaf J., van den Hoogen F. H. J., Radstake T. R. D. J., Toenhake-Dijkstra H., Van Riel P. L. C. M., Van Der Meer J. W. M., Stalenhoef A. F. H., Barrera P., Circulating leptin and adiponectin concentrations during tumor necrosis factor blockade in patients with active rheumatoid arthritis. Journal of Rheumatology 2009 36 4 724 730 2-s2.0-66149104713 10.3899/jrheum.080626
24. Gonzalez-Gay M. A., Llorca J., Garcia-Unzueta M. T., Gonzalez-Juanatey C., De Matias J. M., Martin J., Redelinghuys M., Woodiwiss A. J., Norton G. R., Dessein P. H., High-grade inflammation, circulating adiponectin concentrations and cardiovascular risk factors in severe rheumatoid arthritis. Clinical and Experimental Rheumatology 2008 26 4 596 603 2-s2.0-52649173297
25. Dessein P. H., Woodiwiss A. J., Norton G. R., Tsang L., Solomon A., Independent associations of total and high molecular weight adiponectin with cardiometabolic risk and surrogate markers of enhanced early atherogenesis in black and white patients with rheumatoid arthritis: a cross-sectional study. Arthritis Research & Therapy 2013 15 5, article R128
26. Gonzalez-Gay M. A., Gonzalez-Juanatey C., Rodriguez-Rodriguez L., Miranda-Filloy J. A., Martin J., Llorca J., Lack of association between adipokines and ghrelin and carotid intima-media thickness in patients with severe rheumatoid arthritis. Clinical and Experimental Rheumatology 2011 29 2 358 359 2-s2.0-79959511930
27. Rho Y. H., Chung C. P., Solus J. F., Raggi P., Oeser A., Gebretsadik T., Shintani A., Stein C. M., Adipocytokines, insulin resistance, and coronary atherosclerosis in rheumatoid arthritis. Arthritis and Rheumatism 2010 62 5 1259 1264 2-s2.0-77951710438 10.1002/art.27376
28. Dessein P. H., Woodiwiss A. J., Norton G. R., Solomon A., Rheumatoid arthritis is associated with reduced adiposity but not with unfavorable major cardiovascular risk factor profiles and enhanced carotid atherosclerosis in black Africans from a developing population: a cross-sectional study. Arthritis Research & Therapy 2013 15 4, article R96 2-s2.0-84883205040 10.1186/ar4276
29. Simon A., Megnien J.-L., Chironi G., The value of carotid intima-media thickness for predicting cardiovascular risk. Arteriosclerosis, Thrombosis, and Vascular Biology 2010 30 2 182 185 2-s2.0-75149153388 10.1161/ATVBAHA.109.196980
30. Riccio S. A., House A. A., Spence J. D., Fenster A., Parraga G., Carotid ultrasound phenotypes in vulnerable populations. Cardiovascular Ultrasound 2006 4, article 44 2-s2.0-33751266046 10.1186/1476-7120-4-44 (Pubitemid 44800126)
31. Johnsen S. H., Mathiesen E. B., Joakimsen O., Stensland E., Wilsgaard T., Løchen M.-L., Njølstad I., Arnesen E., Carotid atherosclerosis is a stronger predictor of myocardial infarction in women than in men: a 6-year follow-up study of 6226 persons: the Tromsø study. Stroke 2007 38 11 2873 2880 2-s2.0-35648930406 10.1161/STROKEAHA.107.487264 (Pubitemid 350035678)
32. Ebrahim S., Papacosta O., Whincup P., Wannamethee G., Walker M., Nicolaides A. N., Dhanjil S., Griffin M., Belcaro G., Rumley A., Lowe G. D. O., Carotid plaque, intima media thickness, cardiovascular risk factors, and prevalent cardiovascular disease in men and women: the British regional heart study. Stroke 1999 30 4 841 850 2-s2.0-0032892245 (Pubitemid 29156378)
33. Spence J. D., Hegele R. A., Noninvasive phenotypes of atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology 2004 24 11 e188 e188 2-s2.0-21644454497
34. Johnsen S. H., Mathiesen E. B., Carotid plaque compared with intima-media thickness as a predictor of coronary and cerebrovascular disease. Current Cardiology Reports 2009 11 1 21 27 2-s2.0-63249096867
35. Rourke J. L., Dranse H. J., Sinal C. J., Towards an integrative approach to understanding the role of chemerin in human health and disease. Obesity Reviews 2013 14 3 245 262 2-s2.0-84874022871 10.1111/obr.12009
36. Dessein P. H., Norton G. R., Woodiwiss A. J., Solomon A., Independent relationship between circulating resistin concentrations and endothelial activation in rheumatoid arthritis. Annals of the Rheumatic Diseases 2013 72 9 1586 1588 2-s2.0-84881479107 10.1136/annrheumdis-2013-203587
37. Dessein P. H., Solomon A., Towards the elucidation of the true impact of adipocytokines on cardiovascular risk in rheumatoid arthritis. Arthritis Research & Therapy 2013 14 127
38. Dessein P. H., Tsang L., Norton G. R., Woodiwiss A. J., Solomon A., Retinol binding protein 4 concentrations relate to enhanced atherosclerosis in obese patients with rheumatoid arthritis. PLoS ONE 2014 10.1371/journal.pone. 0092739
39. Dessein P. H., Norton G. R., Woodiwiss A. J., Solomon A., Age impacts on the independent relationships of leptin with cardiometabolic risk and surrogate markers of enhanced early atherogenesis in black and white patients with rheumatoid arthritis: a cross-sectional study. Rheumatology International 2014 34 3 329 339
40. Arnett F. C., Edworthy S. M., Bloch D. A., McShane D. J., Fries J. F., Cooper N. S., Healey L. A., Kaplan S. R., Liang M. H., Luthra H. S., Medsger T. A. Jr., Mitchell D. M., Neustadt D. H., Pinals R. S., Schaller J. G., Sharp J. T., Wilder R. L., Hunder G. G., The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis and Rheumatism 1988 31 3 315 324 2-s2.0-0023945481 (Pubitemid 18091653)
41. Aletaha D., Neogi T., Silman A. J., 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Annals of the Rheumatic Diseases 2010 69 10 1892 2-s2.0-77957262195 10.1136/ard.2010.138461corr1
42. Gülfe A., Aletaha D., Saxne T., Geborek P., Disease activity level, remission and response in established rheumatoid arthritis: performance of various criteria sets in an observational cohort, treated with anti-TNF agents. BMC Musculoskeletal Disorders 2009 10, article 41 2-s2.0-65549149155 10.1186/1471-2474-10-41
43. Myasoedova E., Crowson C. S., Turesson C., Gabriel S. E., Matteson E. L., Incidence of extraarticular rheumatoid arthritis in olmsted county, Minnesota, in 1995-2007 versus 1985-1994: a population-based study. Journal of Rheumatology 2011 38 6 983 989 2-s2.0-79957859112 10.3899/jrheum.101133
44. Levey A. S., Coresh J., Balk E., Kausz A. T., Levin A., Steffes M. W., National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Annals of Internal Medicine 2003 139 7 137 147 2-s2.0-1642494773
45. Dessein P. H., Christian B. F., Solomon A., Which are the determinants of dyslipidemia in rheumatoid arthritis and does socioeconomic status matter in this context? Journal of Rheumatology 2009 36 7 1357 1361 2-s2.0-67650466985 10.3899/jrheum.090288
46. Gepner A. D., Korcarz C. E., Aeschlimann S. E., LeCaire T. J., Palta M., Tzou W. S., Stein J. H., Validation of a carotid intima-media thickness border detection program for use in an office setting. Journal of the American Society of Echocardiography 2006 19 2 223 228 2-s2.0-31944431891 10.1016/j.echo.2005.09. 006 (Pubitemid 43187167)
47. Dessein P. H., Joffe B. I., Veller M. G., Stevens B. A., Tobias M., Reddi K., Stanwix A. E., Traditional and nontraditional cardiovascular risk factors are associated with atherosclerosis in rheumatoid arthritis. Journal of Rheumatology 2005 32 3 435 442 2-s2.0-15044353475 (Pubitemid 40381413)
48. Touboul P.-J., Hennerici M. G., Meairs S., Adams H., Amarenco P., Bornstein N., Csiba L., Desvarieux M., Ebrahim S., Fatar M., Hernandez Hernandez R., Jaff M., Kownator S., Prati P., Rundek T., Sitzer M., Schminke U., Tardif J.-C., Taylor A., Vicaut E., Woo K. S., Zannad F., Zureik M., Mannheim carotid intima-media thickness consensus (2004-2006). An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006. Cerebrovascular Diseases 2007 23 1 75 80 2-s2.0-33846269659 10.1159/000097034 (Pubitemid 46112808)
49. Dessein P. H., Tobias M., Veller M. G., Metabolic syndrome and subclinical atherosclerosis in rheumatoid arthritis. Journal of Rheumatology 2006 33 12 2425 2432 2-s2.0-33846071577 (Pubitemid 46067821)
50. Giles J. T., Allison M., Bingham C. O. III, Scott W. M. Jr., Bathon J. M., Adiponectin is a mediator of the inverse association of adiposity with radiographic damage in rheumatoid arthritis. Arthritis Care and Research 2009 61 9 1248 1256 2-s2.0-69749093928 10.1002/art.24789
51. Evans M. R., Escalante A., Battafarano D. F., Freeman G. L., O'Leary D. H., del Rincõn I., Carotid atherosclerosis predicts incident acute coronary syndromes in rheumatoid arthritis. Arthritis and Rheumatism 2011 63 5 1211 1220 2-s2.0-79955562395 10.1002/art.30265
52. Dessein P. H., Lopez-Mejias R., Gonzalez-Juanatey C., Independent relationship of osteoprotegerin concentrations with endothelial activation and carotid atherosclerosis in patients with severe rheumatoid arthritis. The Journal of Rheumatology 2014 41 3 429 436 10.3899/jrheum.131037
53. Kremers H. M., Nicola P. J., Crowson C. S., Ballman K. V., Gabriel S. E., Prognostic importance of low body mass index in relation to cardiovascular mortality in rheumatoid arthritis. Arthritis and Rheumatism 2004 50 11 3450 3457 2-s2.0-8444233962 10.1002/art.20612 (Pubitemid 39488669)
54. Escalante A., Haas R. W., del Rincón I., Paradoxical effect of body mass index on survival in rheumatoid arthritis: role of comorbidity and systemic inflammation. Archives of Internal Medicine 2005 165 14 1624 1629 2-s2.0-23744474780 10.1001/archinte.165.14.1624 (Pubitemid 41124157)
55. Dessein P. H., Solomon A., Woodiwiss A. J., Norton G. R., Tsang L., Gonzalez-Gay M. A., Marked independent relationship between circulating interleukin-6 concentrations and endothelial activation in rheumatoid arthritis. Mediators of Inflammation 2013 2013 10 510243 10.1155/2013/510243, 2013
56. Sattar N., Nelson S. M., Adiponectin, diabetes, and coronary heart disease in older persons: unraveling the paradox. Journal of Clinical Endocrinology and Metabolism 2008 93 9 3299 3301 2-s2.0-51649124757 10.1210/jc.2008-1435
57. Gonzalez-Gay M. A., Gonzalez-Juanatey C., Piñeiro A., Garcia-Porrua C., Testa A., Llorca J., High-grade C-reactive protein elevation correlates with accelerated atherogenesis in patients with rheumatoid arthritis. Journal of Rheumatology 2005 32 7 1219 1223 2-s2.0-22244456685 (Pubitemid 40995373)
58. Gonzalez-Gay M. A., Gonzalez-Juanatey C., Lopez-Diaz M. J., Piñeiro A., Garcia-Porrua C., Miranda-Filloy J. A., Ollier W. E. R., Martin J., Llorca J., HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis. Arthritis Care and Research 2007 57 1 125 132 2-s2.0-33846998295 10.1002/art.22482
59. Gonzalez-Gay M. A., Garcia-Unzueta M. T., Gonzalez-Juanatey C., Miranda-Filloy J. A., Vazquez-Rodriguez T. R., de Matias J. M., Martin J., Dessein P. H., Llorca J., Anti-TNF- α therapy modulates resistin in patients with rheumatoid arthritis. Clinical and Experimental Rheumatology 2008 26 2 311 316 2-s2.0-43349098447 (Pubitemid 351659139)
60. Koskinen A., Juslin S., Nieminen R., Moilanen T., Vuolteenaho K., Moilanen E., Adiponectin associates with markers of cartilage degradation in osteoarthritis and induces production of proinflammatory and catabolic factors through mitogen-activated protein kinase pathways. Arthritis Research and Therapy 2011 13 6, article R184 2-s2.0-81055126964 10.1186/ar3512